KSPI enters the week with a clear tension: founder Vyacheslav Kim is selling stock into a 3.7% weekly gain while Susquehanna just lifted its price target — a divergence that is harder to ignore than most.
The insider story is the week's most compelling angle. Kim, who serves as Founder and Chairman, sold across multiple tranches on August 7 and 10, offloading roughly 62,000 shares for approximately $5.7 million in combined proceeds at prices ranging from $90.67 to $97.18. That brings the 90-day net to a positive 269,749 shares on paper, but the recent filing cadence suggests a systematic programme rather than opportunistic liquidation. His institutional holding, reported as of August 10, slipped to 37.6 million shares — down nearly 1.84 million from the prior filing. Baring Vostok also trimmed by around 1.81 million shares. Two major holders reducing in parallel, even modestly, is worth flagging.
On the positioning side, the lending market sends a relaxed signal. Borrow availability for KSPI is running at roughly 320% — meaning more than three shares are available to lend for every one already borrowed — well within the normal range and comfortably above the 52-week floor of 185%. Cost to borrow is negligible at 0.45%, easing roughly 6% on the week. Short interest ticked up 16% in a single session on August 11, but at around 1.1 million shares, it remains 43% below where it was a month ago and carries no meaningful squeeze pressure. The borrow market is loose; shorts face no structural stress. Options tell a modestly different story: the put/call ratio has climbed to 1.90, above its 20-day average of 1.79 and running near the upper end of its recent band, though still well short of the 52-week high of 2.06. Hedging demand is elevated but not extreme.
The Street is cautious rather than constructive. Susquehanna's James Friedman raised his target to $100 on August 12 while holding a Neutral rating — a muted endorsement that acknowledges the recent strength without committing to an upgrade. The price target is now just above the current $95.36, leaving almost no implied upside at consensus. JP Morgan's downgrade to Neutral in August 2025 — from Overweight, with the target held at $96 — was never reversed, and the Freedom Broker initiation at Hold ($87) in March underscores the prevailing sideways posture. The valuation picture is cheap in isolation: the price-to-earnings multiple sits at 7.0x, up about 0.4x over 30 days as the stock has recovered, and EV/EBITDA is 4.6x. The EV/EBIT factor scores in the 95th percentile of the universe — the earnings-per-share surprise rank is a perfect 100. The stock is cheap by most conventional measures and has consistently beaten estimates. Yet the analyst community remains in neutral.
The recent earnings backdrop adds colour. KSPI reported second-quarter results on August 10, posting a one-day move of roughly +5.6% — consistent with a strong beat narrative referenced in recent commentary, with net income reportedly surging 42% year-over-year and the user base up 28%. The stock has responded positively; it is up 6.3% over the past month. Among correlated peers, the picture is more mixed this week: OPRT surged 26% on the week while HAPN and NAVI fell around 8% each. SOFI and UPST both drifted lower. KSPI's 3.7% gain stands out as relatively resilient in that context.
The note to watch over coming sessions is whether Kim's selling programme continues at the same pace — and whether the analyst community, anchored near the current price, takes the post-earnings results as reason to re-engage more constructively.
See the live data behind this article on ORTEX.
Open KSPI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
